These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29749532)

  • 1. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
    Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
    Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non‑coding RNA MEG‑3 suppresses gastric carcinoma cell growth, invasion and migration via EMT regulation.
    Jiao J; Zhang S
    Mol Med Rep; 2019 Sep; 20(3):2685-2693. PubMed ID: 31524253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
    Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
    Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
    Wang X; Li X; Wang Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-665 promotes the progression of gastric adenocarcinoma via elevating FAK activation through targeting SOCS3 and is negatively regulated by lncRNA MEG3.
    Tang H; Long Q; Zhuang K; Yan Y; Han K; Guo H; Lu X
    J Cell Physiol; 2020 May; 235(5):4709-4719. PubMed ID: 31650535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of epithelial‑mesenchymal transition in gastric cancer cells by miR‑711‑mediated downregulation of CD44 expression.
    Xiao WS; Li DF; Tang YP; Chen YZ; Deng WB; Chen J; Zhou WW; Liao AJ
    Oncol Rep; 2018 Nov; 40(5):2844-2853. PubMed ID: 30226620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer.
    Sun JG; Li XB; Yin RH; Li XF
    Mol Med Rep; 2020 Dec; 22(6):4567-4578. PubMed ID: 33173977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.
    Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K
    Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MEG3 Inhibits the Epithelial-mesenchymal Transition of Bladder Cancer Cells through the Snail/E-cadherin Axis.
    Wang L; Wang P; Liu B; Zhang H; Wei CC; Xiong M; Luo G; Wang M
    Curr Med Sci; 2024 Aug; 44(4):726-734. PubMed ID: 38990449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
    Terashima M; Tange S; Ishimura A; Suzuki T
    J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA PVT1 promotes the migration of gastric cancer by functioning as ceRNA of miR-30a and regulating Snail.
    Wang L; Xiao B; Yu T; Gong L; Wang Y; Zhang X; Zou Q; Zuo Q
    J Cell Physiol; 2021 Jan; 236(1):536-548. PubMed ID: 32557622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Wang H; Zhang P
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
    Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
    Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer.
    Tian Y; Ma R; Sun Y; Liu H; Zhang H; Sun Y; Liu L; Li Y; Song L; Gao P
    Oncogene; 2020 Jun; 39(25):4854-4868. PubMed ID: 32439864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.